A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in First Tr Exc Trd Fd Ii Nasdaq stock. As of the latest transaction made, Citadel Advisors LLC holds 26,629 shares of EKG stock, worth $493,169. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,629
Previous 26,740 0.42%
Holding current value
$493,169
Previous $455,000 0.66%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$16.42 - $18.39 $1,822 - $2,041
-111 Reduced 0.42%
26,629 $452,000
Q3 2024

Nov 14, 2024

BUY
$15.34 - $17.35 $34,990 - $39,575
2,281 Added 9.33%
26,740 $455,000
Q2 2024

Aug 14, 2024

SELL
$15.35 - $16.82 $9,992 - $10,949
-651 Reduced 2.59%
24,459 $380,000
Q1 2024

May 15, 2024

BUY
$15.25 - $16.97 $382,927 - $426,116
25,110 New
25,110 $426,000

Others Institutions Holding EKG

About FIRST TR EXC-TRD FD II NASDAQ


  • Ticker EKG
  • Sector ETFs
  • Industry ETFs
More about EKG
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.